Aurinia Pharmaceuticals
AUPH
#4717
Rank
NZ$3.31 B
Marketcap
NZ$24.92
Share price
2.99%
Change (1 day)
73.72%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): NZ$0.14 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.26 Billion. In 2024 the company made an earning of NZ$20.68 Million, an increase over its 2023 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.14 B597.06%
2024 NZ$20.68 M-116.44%
2023 -NZ$0.13 Billion-31.8%
2022 -NZ$0.19 Billion-39.4%
2021 -NZ$0.31 Billion61.9%
2020 -NZ$0.19 Billion-9.73%
2019 -NZ$0.21 Billion92.65%
2018 -NZ$0.11 Billion36.39%
2017 -NZ$79.25 Million106.29%
2016 -NZ$38.42 Million-15.4%
2015 -NZ$45.41 Million65.84%
2014 -NZ$27.39 Million129.82%
2013 -NZ$11.92 Million-26.6%
2012 -NZ$16.24 Million
2010 -NZ$9.19 Million-39.22%
2009 -NZ$15.13 Million-43.78%
2008 -NZ$26.9 Million-53.19%
2007 -NZ$57.46 Million42.97%
2006 -NZ$40.2 Million-23.03%
2005 -NZ$52.22 Million36.1%
2004 -NZ$38.37 Million172.57%
2003 -NZ$14.08 Million484.61%
2002 -NZ$2.41 Million
2000 -NZ$11.44 Million453.81%
1999 -NZ$2.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
NZ$8.80 B 6,121.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-NZ$37.25 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-NZ$9.24 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA